The Weekly Litigation News Digest is now live. Subscribe now

Seqirus Uk competitive analysis

Loading summary...

Explore patent oppositions filed by Seqirus Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Method For Producing Rna CompositionsCUREVACOct 1, 2024
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNADec 1, 2022
Nucleic Acid VaccinesMODERNASep 21, 2022
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNASep 1, 2022

Explore Seqirus Uk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jul 15, 2020Improved Methods For Preparing Squalene1
Aug 21, 2019Vaccination With Multiple Clades Of H5 Influenza A Virus1
Feb 6, 2019Manufacture Of An Oil-In-Water Emulsion Comprising Squalene1

Latest PTAB cases involving Seqirus Uk

Discover the latest PTAB cases involving Seqirus Uk, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Seqirus Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SEQIRUS UK43 - -
CUREVAC - 62 - 1
GLAXOSMITHKLINE29112812
MODERNA57542